company? Let’s change
that.
Don't see your company?
Create a company profileCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.
The mission of Alume Biosciences is to make our proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. Learn how you can help us move surgery into the light.
Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. We are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain.
InfraScan is a medical device company.
Lincare is a leading supplier of respiratory-therapy products and services for patients in the home. You can learn more about our extensive suite of products and services by visiting our website. Everywhere we operate, Lincare is working to be a partner in patient care by providing high-quality services and supplies, promoting patient education, and building strong relationships with patients, physicians, families and caregivers. Services we offer include: Oxygen Therapy Nebulizer Therapy Sleep Therapy Ventilator Therapy Enteral Therapy Pediatric Services Caring Responders Long Term Care Disease Management Programs and More!
Notable is a clinical-stage platform therapeutic company developing a new class of precision medicines: predictive precision medicines. Notable aims to be the leader in predictive precision medicine and revolutionize the way in which patients seek and receive treatment: patient population by patient population, and cancer by cancer. By transforming historical standards of care, Notable expects to provide dramatic impact for patients and the healthcare community.
Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.
The mission of Sampling Human is to couple health related decisions to their effects at the single cell level. It is inspired by the founders’ academic and professional efforts to extend what is measurable and to derive what must be measured. The human body is a complex system that cannot be quantified exhaustively or heuristically. Clinical diagnosis today is an imprecise art. On average, diagnosis of rare diseases is 5 years delayed with 50% of delays impacting the outcome. Misdiagnosis is far too common with a 66% likelihood of disagreement between experts. We are stuck with symptoms based medicine. The nature of physiological data is to blame. Decisions today are based on fuzzy variables (tired, drowsy, weak, tingling, itchy, etc). Better decisions will require precise knowledge regarding the fundamental physiological units of our bodies, CELLS.
ScripsAmerica distributes pharmaceutical products, including pain, arthritis, prenatal, urinary, and hormonal replacement drugs.
Bioceptive, a women’s health company, develops an intrauterine device inserter that simplifies the insertion procedure.
ProUroCare Medical develops devices for the detection and characterization of prostate diseases.
Regenexx was the first to use stem cells to treat orthopedic injuries, and we've published roughly half of all worldwide research in their application. With more than 6 million covered lives across the country, Regenexx uses our advanced regenerative technologies to help self-funded employers save up to 80% of their orthopedic healthcare costs by providing an effective, low-cost alternative to roughly 70% of orthopedic surgeries. If given the choice between an orthopedic surgery, or a non-invasive treatment to eliminate pain and improve function and mobility, employees choose the latter 99% of the time. The Regenexx process of treating musculoskeletal conditions involves a high level of physician skill and our patented, research-based protocols that allow us to realize outcomes that can only be achieved through our high standards of practice. We license our patented Interventional Orthopedics procedures to physicians across the country who are part of the Regenexx network. These expert physicians receive intensive initial and ongoing training and support. Learn more about Regenexx and how we help employers take control of their health care spend. Visit www.Regenexxcorporate.com for more information.
OncoSec Medical, a biotechnology company, develops treatments for advanced stage skin cancer patients.
Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments. For more information, visit Cresilon.com. We are always looking for dynamic people to join our team as we dive into a range of challenges at the forefront of science and technology—to learn more about our openings please visit https://cresilon.workable.com/.
AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform.
Assurea is a woman-owned consulting firm known for Quality Compliance and Data Integrity expertise within personalized medicine and the global life sciences industry. We have built a consulting model that is collaborative, flexible, and accelerates the path forward for our partners to serve patients in need. Our team of experts work with our clients to give them options to create a customized plan for establishing quality standards.
Moonlight Therapeutics is focused on developing safe, effective, and patient-friendly treatments for food allergies.
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
Bioquark’s core program focuses on developing a novel class of substances termed combinatorial biologics,
Sigenics was established in December 2000 with one purpose in mind: to provide excellence in silicon. In the beginning, Sigenics’ goal was to develop silicon devices to aid in biomedical research. We have grown to become a designer and supplier of “private-label” silicon chips for Original Equipment Manufacturers (OEM) of electronic equipment in multiple markets including: medical, aerospace, industrial, and military. Today, Sigenics Inc. is an ISO 9001:2015 certified company that specializes in designing, testing and delivering custom integrated circuits for sensor, analog and mixed-signal applications. Here at Sigenics we pride ourselves on transforming ideas into realities. Sigenics enhances the value of customers’ products at every phase - specification, design, simulation, layout, and testing - and continues this process until the products’ requirements are satisfied. Privately-held, Sigenics is headquartered in Chicago,IL with an additional design office in Los Osos, CA.